Skip to content

A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques

A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CRIS
Registry ID
KCT0000490
Enrollment
28
Registered
2012-07-23
Start date
2012-08-16
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Standard of Care (Control Group): Standard of Care (SoC) is a stapled end-to-end or end-to-side anastomosis without the use of a Fibrin Sealant or adjunctive treatment for sealing. EVICEL® Fib

Sponsors

Johnson & Johnson Medical Korea
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Preoperative: 1) Subjects undergoing primary elective lower anterior resection with a stapled end-toend or end-to-side anastomosis; 2) Subjects = 18 years of age who are willing to participate in the study and provide written informed consent prior to any study-related procedures; Intraoperative: 1) Confirmed distance of anastomosis is =12cm from the anal verge, as measured using a rigid rectoscope. 2) Anastomosis with a successful leak test.

Exclusion criteria

Exclusion criteria: Preoperative: 1) Avastin use within 30 days prior to surgery; 2) Known hypersensitivity to the human blood products or the components of the investigational product; 3) Female subjects who are pregnant or nursing; 4) Exposure to another investigational drug or device in a clinical trial within 30 days prior to surgery or for the 90 day follow up period after surgery. Intraoperative: 1) Subject requiring protective ostomy; 2) Subjects with any intra-operative findings identified by the surgeon that may preclude conduct of the study procedures.

Design outcomes

Primary

MeasureTime frame
Absence of clinical anastomotic leak

Secondary

MeasureTime frame
Incidence of clinical anastomotic leak/ Incidence of stricture

Countries

Korea, Republic of

Contacts

Public ContactIn Jeong

Asan Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026